跳至主要内容
临床试验/NCT06384859
NCT06384859尚未招募4 期

Effectiveness of Extracorporeal Shockwave Therapy Combined With Platelet-rich Plasma in the Treatment of Chronic Insertional Achilles Tendinopathy

Mahidol University2 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2024年5月1日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
94
试验地点
2
主要终点
VAS

研究概览

简要总结

The goal of this clinical trial is to learn about the effectiveness of extracorporeal shockwave(ESWT) combined with platelet-rich plasma(PRP) to treat chronic insertional tendinopathy. The main questions it aims to answer are:

Does ESWT combined with PRP treatment reduce the symptom and improve functional score after treatment? What medical complication do participants have when receive the treatment?

Researchers will compare ESWT combined with PRP to ESWT treatment alone to see if ESWT combined with PRP works to treat chronic insertional tendinopathy.

Participants will:

  • Receive ESWT once a week for 4 weeks then receive PRP injection at a week later or ESWT once a week for 4 weeks
  • Visit the clinic at 6 weeks, 3 months, 6 months and 1 year after treatment for checkups and record functional score

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with insertional Achilles tendinopathy
  • Had symptom more than 6 months
  • Failed other standard conservative treatment (rest, medication, activity modification, stretching exercise, and heel lift orthosis)

排除标准

  • Receive corticosteroid injection at the Achilles insertion
  • History of infection around ankle and heel
  • Has neurological deficit
  • Has a contraindication for ESWT(hemophilia, coagulopathy or foot and ankle malignancy)

结局指标

主要结局

VAS

时间窗: 6 week, 3 months, 6 months and 1 year after treatment

Visual Analogue Scale

次要结局

  • VAS-FA(6 week, 3 months, 6 months and 1 year after treatment)
  • FFI(6 week, 3 months, 6 months and 1 year after treatment)
  • FAAM(6 week, 3 months, 6 months and 1 year after treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验